Author/Authors :
KHOSRAVI، ALIREZA نويسنده , , Pourmoghaddas، Masoud نويسنده MD, Professor of Interventional Cardiology, Chamran Heart Hospital, Isfahan University of Medical Sciences, Isfahan , , Ziaie، Fereshteh نويسنده Cardiologist, Chamran Heart Hospital, Isfahan University of Medical Sciences, Isfahan , , Enteshari، Arezoo نويسنده MD, Cardiologist, Alzahra Hospital, Isfahan University of Medical Sciences, Isfahan , , Khaledifa، Arsalan نويسنده MD, Assistant Professor of Cardiology, Hajar Hospital, Shahrekord University of Medical Sciences. Shahrekord , , Bahonar، Ahmad نويسنده Hypertension Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences ,
Abstract :
Objectives: Lipid disorders, lipoproteins, diabetes mellitus, and
hypertension are the known risk factors for coronary artery diseases;
however, their role is unknown in restenosis after coronary
stenting. This study aimed to review the role of these factors, particularly
lipoprotein (a) or Lp (a), as a predictive factor for
restenosis after coronary stenting with Bare Metal Stent.
Methods: In this study, coronary artery stenting was performed
on 170 patients. Follow-up was done using coronary angiography
in 128 patients, 6 months after conducting angioplasty. Clinical
and biochemical characteristics of the patients were collected as
prospective method and were compared between the patients with
and without restenosis.
Results: Restenosis was seen in 46 patients (35.9%). Fasting blood
glucose level (FBG) in patients with restenosis was significantly
higher than patients without restenosis (102.3 ± 39 mg/dl vs. 84.5
± 28.9 [OR: 1.02, 95% CI: 1.00-1.04]). Lp (a) levels (OR: 0.54, 95%
CI: 0.26-1.10) and other biochemical markers and clinical variables
had no correlation with restenosis.
Conclusions: Lipoproteins and lipids may not be the underlying
cause of restenosis but accurate control of diabetes may improve
prognosis after elective coronary stenting.
